Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WRNW still churning at HOD- waiting for the .01 break.
WRNW- if it breaks .01 watch out...
WRNW back at HOD. Very nice chart!
WHKA and WRNW looking good today!
WHKA filled the gap and holding well here= not many sellers at this level.
WHKA gapping here! .012 (2) x .0125
Looking forward to some nice action here today- hopefully can pick up a bunch more on a dip for our run at .03 the next couple of days. GL!
WHKA gapping up a little with HILL on the bid at .013. Might not be able to get many cheap shares today :(
Judging by the volume and close on Fri, WHKA might be where it's at today. I think we test .03 by Weds morning.
GM! Hoping for a great week here!
Yep- With all that great volume and closing HOD on a Friday that definitely signals a great couple days for WHKA. I'll be buying all the dips. I think .03-04 is our short term goal- if we clear that it will be explosive.
Right, I'm jealous. Any of these POSs can run. You're up maybe 100% on that piece of crap- if you can actually even sell it. In the months that you've had your assets ($200) tied up in CTTJ, I'm up over 400%. Oh yeah of your 3 picks from 3/31 ATLJ from .0046 to .0025 today (never higher than when you picked it)- XTMS from .0022 to .0018 today. DNDN you did good on- like everyone else.
Good job with OMR! I like a lot of your picks- do you ever short any larger cap stocks? I can't wait for PHM (pulte homes) to fall through $25 so I can short the heck out of it. I shorted it yesterday morning and then covered when I saw it not going my way. Anyway would be interested to hear some of your short picks since I think we might be doing lots of shorting this summer.
Doesn't look too bad I guess. Really thought it would pop this morning so I gave it a few minutes and then sold even. Gotta be honest with you this has been a terrible week. Other than BHUB (where I scored BIG) I've sucked this week. Tried flipping DYAX a few times and got killed. Bought some WHKA so maybe that will be redeeming.
Yeah- I think WHKA should run pretty nicely next week. Held up really well for EOD and EOW too. GL!
That's great- did you double your $200 yet?
WHKA- had a big buy on the bid the last hour and only got 5000.
Might try to buy some WHKA for next week if we get a dip here. Lotsa volume today...
Got a bunch of DYAX at 6.6
CBRX is MOVING UP! check the chart!!!
Hey- I'm OMR too. Also check CBRX- moving up!
CBRX starting to gap. You HAVE to check this chart out
CBRX is going to pop today- the 50dma is at 3.25 which is also close to first resistance. i think it's going to make a run for that area from 1.80. This setup is BEAUTIFUL!
DYAX will be a good play today- but they might take it down for the first little while like they did to DNDN.
CBRX is where it's at today folks. PLEASE check this chart- closed at 1.80 yesterday on High volume- a breakout from the highest trading level since its huge fall from 6.00. Resistance is at 2.75 so I bet we could hit 2.50 today or Monday esp if some shorts start covering because of any potential news. +50% potential here today! GL
CBRX is where it's at today folks. PLEASE check this chart- closed at 1.80 yesterday on High volume- a breakout from the highest trading level since its huge fall from 6.00. Resistance is at 2.75 so I bet we could hit 2.50 today or Monday esp if some shorts start covering because of any potential news. +50% potential here today! GL
CBRX- mark it down. The chart is smoking for a bounce- looking for around $3 on this. BEAUTIFUL chart- for some reason reminds me a FORG type recovery in progress.
OMR- Bought this on a resistance break. They were recently selected by the Govt of Spain to excavate what's believed to the wreckage of the 1694 HMS Sussex which is believed to have sunk with a "large" amount of gold coin.
I am having a REALLY CRAPPY trading day today....argggggggggg....
Nevermind ADXS- not looking to great right now. We'll have to watch and see how it closes here...
MGLG and ADXS both doing well here. Check the charts on these- looking good!
ADXS- check out L2- really heating up here.
ADXS- getting some bid support now.
OLD PR
Two Leading Biotech Publications Report on Advaxis' Listeria Platform Technology
Advaxis' John Rothman Recognized as one of 20 Notable People in R&D
Mar 15, 2007 9:06:00 AM
Copyright Business Wire 2007
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--
Advaxis, Inc. (OTCBB: ADXS), a biotechnology company developing novel Listeria-based therapeutic cancer vaccines, has been profiled in both Genetic Engineering News and R&D Directions, two leading biotech publications. The publications highlighted Advaxis' Listeria platform technology and their advancement in building a family of cancer vaccines based on exploiting the powerful immune response and antigen-carrying capabilities of the bacterium Listeria monocytogenes.
The profile in the March 1st, 2007 issue of Genetic Engineering News, noted how bacterium-based stimulation of the immune system could hold the key to combating various types of cancers. The article detailed how the Company co-opts the immune mechanisms normally enlisted against the Listeria pathogen, and redirects them against various cancers by engineering cancer-specific antigens into Listeria. The article further explained how Advaxis has improved upon this panel of immune responses through the use of an antigen fusion protein based on the Listeria enzyme listeriolysin O (LLO). When the APC ingests a foreign Listeria and tries to kill it, ingested Listeria secretes this enzyme, which opens a hole in the wall of the digestive vacuole and allows the bacterium to escape into the cytoplasm.
"Listeria induces a strong, cell-mediated immune response that results from its unusual life cycle and is particularly suited to killing cancer cells," says John Rothman, Ph.D., VP of Clinical Development in the article. The bacterium preferentially infects antigen-presenting cells (APC), which activate the immune system and present specific antigens for the immune system to attack.
In the February 2007 issue of R&D Directions, Dr. Rothman was inaugurated as one of 20 Notable People in Research & Development. The article, penned by Lyle Fitzsimmons, profiled several leaders whose contributions have resulted in new areas of drug development for the pharmaceutical industry. Dr. Rothman's distinguished biotech career, from infectious diseases to cancer, was noted in the article. The article also described how Advaxis has expanded the Listeria-antigen idea into nine development-stage vaccines for treating cervical cancer, breast, ovarian, prostate, lung, pancreatic, and skin cancers.
The Genetic Engineering News Article can be seen on the following link: http://www.genengnews.com/articles/chitem.aspx?aid=2022. The R&D Directions will be provided upon request to jvasquez@investorrelationsgroup.com
About Advaxis
Based in North Brunswick, New Jersey, Advaxis is developing proprietary Listeria cancer vaccines based on technology developed by Dr. Yvonne Paterson, professor of microbiology at the University of Pennsylvania, and chairperson of Advaxis' Scientific Advisory Board. Advaxis' is developing therapeutic cancer vaccines that enhance the immune system's cancer-fighting abilities through its proprietary Listeria monocytogenes based system, which utilizes two immunological mechanisms (Innate and Classical Immunity) to develop safer and more effective Listeria based cancer vaccines. Advaxis is the exclusive licensee of a patented broadly enabling Listeria platform technology that can elicit effective anti-tumor responses. Advaxis' lead Listeria vaccine candidate, Lovaxin C, targets cervical and head and neck cancers. Further Listeria vaccines in development target breast, ovarian and lung cancers. Advaxis has entered a Phase I/II clinical trial. The Listeria platform will also have applications in the fields of infectious disease and autoimmune disorders.
Dang- check out the hourly chart on ADXS- if .37 falls this should really start rolling!
ADXS- some more buys at the ask...
Bought some ADXS in case it pops this afternoon. Chart looks interesting here. Big spike yesterday on volume and consolidating well today
MGLG gapping up after that late day shake yesterday. Could be explosive after dropping from 5.5 to .2. GL
Watch MGLG and ADXS today- interesting charts. And MGLG is UTing pm.
Stocks to short- PHM, MTH, RNWK, LGND
Anyone know anything about ADXS? Had a huge pop yesterday through resistance- might be worth watching for a follow through.
Guys- we are going to have great fun shorting the next few days and weeks. Here's a few that I found particularly juicy to short-
NRMX short at 13 -target 9
RNWK short at 7.5 -target 5.5
PHM short at 26 -target 18
LGND short at 7 -target 5
Gonna be fun..GL
MGLG- holding onto some of mine for tomorrow. Think there's still a lot left in this...